Dietary supplementation with n‐3 fatty acids may impair glucose homeostasis in patients with non‐insulin‐dependent diabetes mellitus
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects on lipoprotein and glucose metabolism of addition of n‐3 fatty acids were studied in 14 non‐insulin‐dependent diabetic patients who were given 10g of MaxEPA (3g n‐3 fatty acids) or placebo (olive oil) per day in a randomized double‐blind cross‐over study during two consecutive 8‐week periods. After MaxEPA treatment, there was a marked increase in long‐chain polyunsaturated fatty acids of the n‐3 series in the plasma lipid esters and in the platelet phospholipids, while the n‐6 fatty acid content decreased. The very low density lipoprotein (VLDL) triglyceride concentrations decreased significantly (by 22%) on MaxEPA treatment. However, these changes were not significantly different from those observed during the placebo period. The blood glucose concentration tended to increase during MaxEPA treatment, and to decrease during the placebo period, the changes under the two regimes being significantly different (P < 0.01). In addition, the rate constant for glucose disappearance (k value) for the intravenous insulin‐tolerance test, which reflected the peripheral insulin sensitivity, tended to decrease during MaxEPA treatment and increase during administration of the placebo, there being a significant difference (P < 0.03) between the changes during the two treatments. The reason for the observed changes in blood glucose concentration and peripheral insulin sensitivity is still unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
GLAUBER, H., WALLACE, P., GRIVER, K., & BRECHTEL, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-663 · Cited by 285
Cited by
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338
OKUYAMA, H. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00012-4 · Cited by 292
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282
Metadata
- Authors
- VESSBY, B., & BOBERG, M.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1990-08
- Volume
- 228
- Issue
- 2
- Pages
- 165-171
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2049124795
- Cited by
- 64
- References
- 1
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dietary supplementation with n‐3 fatty acids may impair glucose homeostasis in patients with non‐insulin‐dependent diabetes mellitus. https://app.cochat.ai/papers/10.1111/j.1365-2796.1990.tb00211.x
- The paper
- VESSBY, B., & BOBERG, M. (1990). Dietary supplementation with n‐3 fatty acids may impair glucose homeostasis in patients with non‐insulin‐dependent diabetes mellitus. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1990.tb00211.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.